{
  "meta": {
    "title": "22_Anti-Manic_Drugs",
    "url": "https://brainandscalpel.vercel.app/22-anti-manic-drugs-b7530b80.html",
    "scrapedAt": "2025-11-30T12:34:12.281Z"
  },
  "questions": [
    {
      "text": "Which is a mood stabiliser with an anti-suicidal role?",
      "choices": [
        {
          "id": 1,
          "text": "Carbamazepine"
        },
        {
          "id": 2,
          "text": "Lamotrigine"
        },
        {
          "id": 3,
          "text": "Lithium"
        },
        {
          "id": 4,
          "text": "Valproate"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Lithium</strong> is a mood stabilizer with an<strong> antisuicidal role</strong>.</p>\n<p><strong>Maintenance</strong> treatment with <strong>lithium</strong> has shown to<strong> decrease</strong> the rate of<strong> suicide</strong> in<strong> mood disorders</strong>. Lithium was found to be better than other mood stabilizers such as carbamazepine, lamotrigine, and valproate.</p>\n<p>Lithium is also used in recurrent depression with a cyclic pattern is controlled by either lithium or imipramine. It is also used to augment standard antidepressant response in acute major depression in those patients who have had an inadequate response to monotherapy.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC9508",
      "difficulty": "easy"
    },
    {
      "text": "A 25-year-old man is brought to the psychiatry OPD by his mother with complaints that he has been behaving aggressively for the last 10 days. He believes he owns the biggest automobile company in the world and talks about how his made-up company will put satellites into space someday.  She also says that he sleeps for only 3 hours a day. Which of the following drugs cannot be used to treat this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Sodium valproate"
        },
        {
          "id": 2,
          "text": "Lamotrigine"
        },
        {
          "id": 3,
          "text": "Carbamazepine"
        },
        {
          "id": 4,
          "text": "Lithium"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The clinical features given are suggestive of <strong>acute mania</strong> in this patient and lamotrigine is not indicated in this condition.</p>\n<p>It requires a <strong>slow, extended titration</strong> to minimize the risk of Stevens-Johnson syndrome and&nbsp;is used for <strong>maintenance therapy</strong> in<strong> bipolar disorder</strong>.&nbsp;</p>\n<p>Lithium, sodium valproate, carbamazepine, and atypical antipsychotics are indicated in acute mania.</p>\n<p>Lithium is indicated in both acute mania and maintenance therapy.</p><hr><h3>Related Pearl: Treatment of acute manic episode</h3><p>There is no single drug of choice for the treatment of acute mania.&nbsp;</p>\n<p>If the patient is <strong>on anti-depressants</strong>: Stop antidepressants.&nbsp;</p>\n<p>If the patient is <strong>already on anti-manic medication</strong>:&nbsp;</p>\n<ul>\n<li>If already on lithium or valproate: increase the dose of lithium or valproate and consider adding an antipsychotic.&nbsp;</li>\n<li>Consider adding short-term benzodiazepines for all patients.&nbsp;</li>\n</ul>\n<p>If the patient is <strong>not on anti-manic medication</strong>:</p>\n<ul>\n<li>Consider an antipsychotic if symptoms are severe and behavior is disturbed (or)</li>\n<li>Consider valproate, but avoid in women of reproductive age (or)</li>\n<li>Consider lithium if future adherence is likely&nbsp;</li>\n<li>Consider adding short-term benzodiazepines for all patients.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2381",
      "difficulty": "hard"
    },
    {
      "text": "A patient is being treated with lithium for manic-depressive psychosis.  Which of the following is true about the use of this drug?",
      "choices": [
        {
          "id": 1,
          "text": "Can be given alone for acute episodes"
        },
        {
          "id": 2,
          "text": "Serum concentration monitoring is not used for dose adjustment"
        },
        {
          "id": 3,
          "text": "Cause benign and reversible flattening of T wave on ECG"
        },
        {
          "id": 4,
          "text": "Causes significant weight loss"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Prolonged</strong> use of <strong>lithium</strong> causes a <strong>benign</strong> and <strong>reversible flattening</strong> of <strong>T-wave.</strong></p>\n<p>Option A: Lithium is usually<strong> not given</strong> <strong>alone </strong>in<strong> acute episodes</strong> as the onset of antimanic action is slow. Benzodiazepines, anticonvulsants, or atypical antipsychotics are administered along with lithium in the early phases of treatment.</p>\n<p>Option B: Lithium has a very <strong>narrow therapeutic index </strong>and&nbsp;monitoring of serum concentration is used for guiding dose adjustment.<strong>&nbsp;</strong></p>\n<p>Option D: Lithium causes significant <strong>weight gain</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2384",
      "difficulty": "medium"
    },
    {
      "text": "A patient on lithium therapy is diagnosed to be hypertensive. Which of the following antihypertensive drugs is contraindicated here?",
      "choices": [
        {
          "id": 1,
          "text": "Clonidine"
        },
        {
          "id": 2,
          "text": "Beta blockers"
        },
        {
          "id": 3,
          "text": "Calcium channel blockers"
        },
        {
          "id": 4,
          "text": "Thiazide diuretics"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Thiazides</strong> are <strong>contraindicated</strong> in patients who are on <strong>lithium therapy.</strong></p>\n<p>Thiazide diuretics cause significant<strong> reductions</strong> in<strong> Li<sup><span>+</span></sup> clearance</strong> that result in <strong>toxic</strong> levels.</p>\n<p>The <strong>K+ sparing diuretics</strong> have modest effects on lithium excretion, with a mild increase in serum levels.&nbsp;</p>\n<p>Loop diuretics have a limited impact on Li<sup>+</sup> serum levels.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2387",
      "difficulty": "easy"
    },
    {
      "text": "A patient with a history of mania, on lithium therapy, is brought with complaints of vomiting and multiple episodes of diarrhea. On examination, coarse tremors and an ataxic gait are noted. What is the expected level of serum lithium in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "> 1.2 mEq/L"
        },
        {
          "id": 2,
          "text": "> 0.8 mEq/L"
        },
        {
          "id": 3,
          "text": "> 1.5 mEq/L"
        },
        {
          "id": 4,
          "text": "> 0.5 mEq/L"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Clinical features are suggestive of<strong data-stringify-type=\"bold\">&nbsp;lithium toxicity,&nbsp;</strong>where serum<strong data-stringify-type=\"bold\">&nbsp;</strong><span data-stringify-type=\"bold\">levels&nbsp;</span><strong data-stringify-type=\"bold\">&gt;1.5 mEq/L&nbsp;</strong>are considered<strong data-stringify-type=\"bold\">&nbsp;toxic.&nbsp;&nbsp;</strong></p>\n<p>Lithium has a <strong>narrow therapeutic index (0.8&ndash;1.2 mEq/L)</strong>&nbsp;and therefore requires monitoring to suspect toxicity. The toxic effects of lithium usually start manifesting when the serum level crosses 1.5 mEq/L.</p>\n<p>Acute intoxication is characterized by:&nbsp;</p>\n<ul>\n<li>Vomiting</li>\n<li>Profuse diarrhea</li>\n<li>Coarse tremors</li>\n<li>Ataxia</li>\n<li>Coma</li>\n<li>Convulsions.</li>\n</ul>\n<p>A fine action tremor is common in patients taking lithium at therapeutic doses and can develop at any time during treatment.&nbsp;Therapeutic lithium tremor is generally symmetric, limited to the arms, and nonprogressive.Tremor from lithium toxicity is <strong>coarser</strong> and <strong>more disabling</strong>, may also affect the legs, and occurs with other symptoms of toxicity.</p>\n<p>Serious effects of lithium toxicity will involve confusion, hyperreflexia, and seizures. Motor and cognitive side effects can become irreversible with<strong> persistent cerebellar tremor</strong> being the most common.&nbsp;</p><hr><h3>Related Pearl: Lithium in bipolar disorder</h3><table>\n<tbody>\n<tr>\n<td>\n<div><strong>Guidelines for Lithium therapy</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Indications</strong>:</div>\n<div>Mania, hypomania, bipolar disorder, etc.</div>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Blood levels of lithium</strong>:</p>\n<p>For <strong>therapeutic</strong> purpose (treatment of acute mania) :&nbsp;<strong>0.8-1.2 mEq/L</strong></p>\n<p>For <strong>prophylaxis</strong> (to prevent relapse of bipolar disorder):&nbsp;<strong>0.5-0.8 mEq/L</strong></p>\n<p><strong>Toxic</strong> levels of lithium:&nbsp;<strong>&gt;/= 1.5 mEq/L</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Contraindications</strong>:</div>\n<div>\n<ul>\n<li>CKD</li>\n<li>Heart disease</li>\n<li>Hyponatremia or diuretic use</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Baseline studies:</strong></div>\n<div>\n<ul>\n<li>BUN (Blood Urea Nitrogen), Creatinine, Calcium, Urine analysis</li>\n<li>Thyroid function test</li>\n<li>ECG in patients with coronary risk factors</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Acute a</strong><strong>dverse effects</strong>:</div>\n<div>\n<ul>\n<li>Tremor, ataxia, weakness</li>\n<li>Polyuria, polydipsia</li>\n<li>Vomiting, diarrhea</li>\n<li>Cognitive impairment</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Chronic a</strong><strong>dverse effects</strong>:</div>\n<div>\n<ul>\n<li>Nephrogenic diabetes insipidus</li>\n<li>Thyroid dysfunction</li>\n<li>Hyperparathyroidism</li>\n</ul>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2392",
      "difficulty": "easy"
    },
    {
      "text": "At what serum lithium levels would you consider dialysis in acute lithium toxicity?",
      "choices": [
        {
          "id": 1,
          "text": "> 2.0 mEq/L"
        },
        {
          "id": 2,
          "text": "> 4.0 mEq/L"
        },
        {
          "id": 3,
          "text": "> 3.0 mEq/L"
        },
        {
          "id": 4,
          "text": "> 1.5 mEq/L"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In acute overdoses, <strong>hemodialysis</strong> is indicated in:&nbsp;</p>\n<ul>\n<li>Serum lithium level is<strong>&nbsp;&gt; 4.0 mEq/L</strong></li>\n<li>Patients exhibiting&nbsp;<strong>symptoms&nbsp;</strong>of toxicity.</li>\n</ul>\n<p>Note: While hemodialysis is considered when serum lithium level is 4.0 mEq/L and above, signs of lithium toxicity usually start showing when the serum level is &gt; 1.5 mEq/L. One should not get confused between the two.&nbsp;</p><p>This is a <strong>controversial</strong> topic. There is a difference of opinion between authors.</p>\n<ul>\n<li>Goodman and Gilman mention that hemodialysis should be initiated&nbsp;in patients exhibiting symptoms of toxicity or if serum lithium levels exceed 3.0 mEq/L.</li>\n<li>Kaplan and Sadock's and Harrison's, mention that hemodialysis is to be initiated if the patient is severely symptomatic or serum level of lithium is 4 mEq/L.</li>\n<li>In clinical practice serum lithium levels many a time do not correlate with clinical signs of toxicity.&nbsp;</li>\n</ul><hr><h3>Related Pearl: Lithium in bipolar disorder</h3><table>\n<tbody>\n<tr>\n<td>\n<div><strong>Guidelines for Lithium therapy</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Indications</strong>:</div>\n<div>Mania, hypomania, bipolar disorder, etc.</div>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Blood levels of lithium</strong>:</p>\n<p>For <strong>therapeutic</strong> purpose (treatment of acute mania) :&nbsp;<strong>0.8-1.2 mEq/L</strong></p>\n<p>For <strong>prophylaxis</strong> (to prevent relapse of bipolar disorder):&nbsp;<strong>0.5-0.8 mEq/L</strong></p>\n<p><strong>Toxic</strong> levels of lithium:&nbsp;<strong>&gt;/= 1.5 mEq/L</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Contraindications</strong>:</div>\n<div>\n<ul>\n<li>CKD</li>\n<li>Heart disease</li>\n<li>Hyponatremia or diuretic use</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Baseline studies:</strong></div>\n<div>\n<ul>\n<li>BUN (Blood Urea Nitrogen), Creatinine, Calcium, Urine analysis</li>\n<li>Thyroid function test</li>\n<li>ECG in patients with coronary risk factors</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Acute a</strong><strong>dverse effects</strong>:</div>\n<div>\n<ul>\n<li>Tremor, ataxia, weakness</li>\n<li>Polyuria, polydipsia</li>\n<li>Vomiting, diarrhea</li>\n<li>Cognitive impairment</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Chronic a</strong><strong>dverse effects</strong>:</div>\n<div>\n<ul>\n<li>Nephrogenic diabetes insipidus</li>\n<li>Thyroid dysfunction</li>\n<li>Hyperparathyroidism</li>\n</ul>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2393",
      "difficulty": "medium"
    },
    {
      "text": "Patients with which of the following conditions do not warrant lithium therapy?",
      "choices": [
        {
          "id": 1,
          "text": "Chemotherapy induced neutropenia"
        },
        {
          "id": 2,
          "text": "Major depression"
        },
        {
          "id": 3,
          "text": "Vasculogenic headache"
        },
        {
          "id": 4,
          "text": "Generalised anxiety disorder"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Lithium is not indicated in generalized anxiety disorder.</p>\n<p><strong>Bipolar disorder </strong>is the primary indication for<strong> lithium. </strong></p>\n<p>Option A: Effect of leukocytosis may hasten recovery from cancer chemotherapy-induced leukopenia and agranulocytosis.</p>\n<p>Option B: Unipolar depression can be treated with lithium as an adjuvant in resistant cases.&nbsp; &nbsp;&nbsp;</p>\n<p>Option C: Vasculogenic headaches like cluster headaches.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2395",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following must be administered initially in patients with acute mania with psychotic features?",
      "choices": [
        {
          "id": 1,
          "text": "Lithium"
        },
        {
          "id": 2,
          "text": "Olanzapine"
        },
        {
          "id": 3,
          "text": "Carbamazepine"
        },
        {
          "id": 4,
          "text": "Sodium valproate"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In acute mania, even in patients without overt psychotic manifestations,<strong> atypical antipsychotics</strong> like<strong> olanzapine </strong>is used initially for<strong> rapid control of psychosis.</strong> Atypical antipsychotics are also effective as monotherapy.&nbsp;</p>\n<p>The therapeutic effects of lithium, carbamazepine, and valproic acid are seen only after a few days. Therefore they are effective only with daily dosing with adequate serum monitoring.</p><hr><h3>Related Pearl: Treatment of acute manic episode</h3><p>There is no single drug of choice for the treatment of acute mania.&nbsp;</p>\n<p>If the patient is <strong>on anti-depressants</strong>: Stop antidepressants.&nbsp;</p>\n<p>If the patient is <strong>already on anti-manic medication</strong>:&nbsp;</p>\n<ul>\n<li>If already on lithium or valproate: increase the dose of lithium or valproate and consider adding an antipsychotic.&nbsp;</li>\n<li>Consider adding short-term benzodiazepines for all patients.&nbsp;</li>\n</ul>\n<p>If the patient is <strong>not on anti-manic medication</strong>:</p>\n<ul>\n<li>Consider an antipsychotic if symptoms are severe and behavior is disturbed (or)</li>\n<li>Consider valproate, but avoid in women of reproductive age (or)</li>\n<li>Consider lithium if future adherence is likely&nbsp;</li>\n<li>Consider adding short-term benzodiazepines for all patients.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1323",
      "difficulty": "medium"
    },
    {
      "text": "A patient with mania has been initiated on lithium therapy. While counseling the patient about the medication, which of the following effects do you mention as the most common CNS adverse effect?",
      "choices": [
        {
          "id": 1,
          "text": "Ataxia"
        },
        {
          "id": 2,
          "text": "Slurred speech"
        },
        {
          "id": 3,
          "text": "Fine tremors"
        },
        {
          "id": 4,
          "text": "Coarse tremors"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The <strong>most common CNS adverse effect</strong> of <strong>lithium</strong> in the therapeutic dose range is<strong> fine postural hand tremors.&nbsp;</strong>Therapeutic lithium tremor is generally symmetric, limited to the arms, and nonprogressive.</p>\n<p>Options A and B: Ataxia, slurred speech, and/or incoordination are adverse effects seen during peak CNS/serum concentrations. Single bedtime dosing can avoid these adverse effects.</p>\n<p>Option D:&nbsp;Coarse tremors are seen in case of lithium toxicity and is&nbsp;&nbsp;more disabling and may also affect the legs.</p><hr><h3>Related Pearl: Lithium in bipolar disorder</h3><table>\n<tbody>\n<tr>\n<td>\n<div><strong>Guidelines for Lithium therapy</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Indications</strong>:</div>\n<div>Mania, hypomania, bipolar disorder, etc.</div>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Blood levels of lithium</strong>:</p>\n<p>For <strong>therapeutic</strong> purpose (treatment of acute mania) :&nbsp;<strong>0.8-1.2 mEq/L</strong></p>\n<p>For <strong>prophylaxis</strong> (to prevent relapse of bipolar disorder):&nbsp;<strong>0.5-0.8 mEq/L</strong></p>\n<p><strong>Toxic</strong> levels of lithium:&nbsp;<strong>&gt;/= 1.5 mEq/L</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Contraindications</strong>:</div>\n<div>\n<ul>\n<li>CKD</li>\n<li>Heart disease</li>\n<li>Hyponatremia or diuretic use</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Baseline studies:</strong></div>\n<div>\n<ul>\n<li>BUN (Blood Urea Nitrogen), Creatinine, Calcium, Urine analysis</li>\n<li>Thyroid function test</li>\n<li>ECG in patients with coronary risk factors</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Acute a</strong><strong>dverse effects</strong>:</div>\n<div>\n<ul>\n<li>Tremor, ataxia, weakness</li>\n<li>Polyuria, polydipsia</li>\n<li>Vomiting, diarrhea</li>\n<li>Cognitive impairment</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Chronic a</strong><strong>dverse effects</strong>:</div>\n<div>\n<ul>\n<li>Nephrogenic diabetes insipidus</li>\n<li>Thyroid dysfunction</li>\n<li>Hyperparathyroidism</li>\n</ul>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2396",
      "difficulty": "medium"
    },
    {
      "text": "A patient on chronic lithium therapy is diagnosed to have hypothyroidism. What should be the next course of action?",
      "choices": [
        {
          "id": 1,
          "text": "Stop lithium immediately and start exogenous thyroid replacement"
        },
        {
          "id": 2,
          "text": "Stop lithium immediately and wait for normalisation of thyroid status"
        },
        {
          "id": 3,
          "text": "Continue lithium along with exogenous thyroid replacement"
        },
        {
          "id": 4,
          "text": "Decrease the dose of lithium and wait for normalisation of thyroid status"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Hypothyroidism</strong> developed in a patient on chronic lithium therapy is&nbsp;treated by <strong>exogenous replacement</strong> of <strong>thyroid hormones.</strong></p>\n<p>It is <strong>not a reason</strong> for the<strong> discontinuation</strong> of lithium therapy.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1325",
      "difficulty": "medium"
    },
    {
      "text": "A 34-year-old woman presents with complaints of increased frequency of urination and fatigue. She gives a history of lithium intake for bipolar mood disorder for the past 6 years. On investigations, her serum osmolality was 300 mOsm/L  and her urine osmolality was 250 mOsm/L. Which of the following drugs is used to treat this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Amiloride"
        },
        {
          "id": 2,
          "text": "Demeclocycline"
        },
        {
          "id": 3,
          "text": "Thiazide diuretics"
        },
        {
          "id": 4,
          "text": "Indomethacin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario with a history of lithium intake and investigations showing <strong>&uarr;serum osmolality</strong> and <strong>&darr;urine osmolality</strong> is suggestive of <strong>nephrogenic diabetes insipidus</strong> secondary to <strong>lithium toxicity</strong>. <strong>Amiloride</strong> is the drug of choice for this condition.&nbsp;</p>\n<p>Amiloride is a <strong>potassium-sparing diuretic</strong>. It inhibits the renal epithelial Na<sup>+</sup> channel&nbsp;(ENac channel) in collecting duct cells. It&nbsp;<strong>blocks</strong> the entry of <strong>Li<sup>+</sup> ions </strong>through the<strong>&nbsp;ENac channels</strong> and thus mitigates diabetes insipidus induced by lithium.</p>\n<p><strong>&nbsp;</strong>Thiazide diuretics cause significant<strong> reductions</strong> in<strong> Li<sup><span>+</span></sup> clearance</strong> that result in <strong>toxic</strong> levels.&nbsp;<strong>Thiazides</strong> are <strong>contraindicated</strong> in patients who are on <strong>lithium therapy.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2398",
      "difficulty": "medium"
    },
    {
      "text": "A female patient is on first-line pharmacological therapy for bipolar disorder for 6 months. She is fasting for a few days due to religious reasons and presented with seizures, coarse tremors, confusion, and weakness of limbs. Which of the following investigations should be done to help diagnose her condition?",
      "choices": [
        {
          "id": 1,
          "text": "Serum potassium level"
        },
        {
          "id": 2,
          "text": "Serum lithium level"
        },
        {
          "id": 3,
          "text": "ECG"
        },
        {
          "id": 4,
          "text": "MRI"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The clinical features given in the question are most likely suggestive of <strong>lithium</strong> <strong>toxicity</strong>, and hence <strong>serum lithium levels</strong> should be measured to confirm it.</p>\n<p><strong>Lithium</strong>&nbsp;is a <strong>mood stabilizer</strong> with a very narrow therapeutic index and is the <strong>first line</strong> of management in <strong>bipolar disorder</strong>.</p>\n<p>The kidney handles both <strong>lithium</strong> and&nbsp;<strong>Na</strong><sup><strong>+</strong>&nbsp;</sup>in the same way via <strong>ENac channel</strong>. Thus during <strong>fasting/dehydration</strong>, along with&nbsp;<strong>Na<sup>+&nbsp;</sup>reabsorption</strong> in renal tubules, there will be an&nbsp;increase in the&nbsp;<strong>reabsorption of&nbsp;lithium&nbsp;</strong>leading to lithium toxicity.</p>\n<p>Lithium has a very narrow therapeutic index of&nbsp;<strong>0.8-1.2 mEq/L.</strong>&nbsp;The severity of lithium toxicity is often divided into the following three grades:&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Grade</strong></td>\n<td>\n<p><strong>Sr. lithium concentration </strong>(in mEq/L)</p>\n</td>\n<td><strong>Symptoms</strong></td>\n</tr>\n<tr>\n<td><strong>Mild symptoms</strong></td>\n<td><strong>1.5-2.5&nbsp;</strong></td>\n<td>nausea, vomiting, <strong>tremor</strong>, and fatigue</td>\n</tr>\n<tr>\n<td><strong>Moderate intoxication</strong></td>\n<td><strong>2.5-3.5&nbsp;</strong></td>\n<td><strong>confusion</strong>, agitation, delirium, tachycardia, and hypertonia</td>\n</tr>\n<tr>\n<td><strong>Severe intoxication</strong></td>\n<td><strong>&gt;3.5&nbsp;</strong></td>\n<td>coma, <strong>seizures</strong>, hyperthermia, and hypotension</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>A fine tremor is common in patients taking lithium at therapeutic doses.&nbsp;Therapeutic lithium tremor is generally symmetric, limited to the arms, and nonprogressive. The tremor from <strong>lithium toxicity</strong> is&nbsp;<strong>coarser</strong>&nbsp;and&nbsp;<strong>more disabling</strong>, may also affect the legs, and occurs with other symptoms of toxicity.&nbsp;Other adverse effects include&nbsp;mental confusion, <strong>hypothyroidism</strong>, <strong>nephrogenic</strong>&nbsp;<strong>diabetes insipidus,</strong>&nbsp;and&nbsp;edema.</p>\n<p>As lithium is readily dialyzed, lithium overdose or toxicity is treated with <strong>hemodialysis</strong>.</p>\n<p>*Note - Serum&nbsp;<strong>Na</strong><sup><strong>+</strong>&nbsp;</sup>levels are significant with respect to&nbsp;<strong>lithium toxicity</strong>, where as serum potassium levels becomes significant in <strong>digoxin toxicity</strong>.&nbsp;<strong>Hypokalemia </strong>increases&nbsp;the&nbsp;risk&nbsp;of digoxin&nbsp;toxicity.</p><hr><h3>Related Pearl: Lithium in bipolar disorder</h3><table>\n<tbody>\n<tr>\n<td>\n<div><strong>Guidelines for Lithium therapy</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Indications</strong>:</div>\n<div>Mania, hypomania, bipolar disorder, etc.</div>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Blood levels of lithium</strong>:</p>\n<p>For <strong>therapeutic</strong> purpose (treatment of acute mania) :&nbsp;<strong>0.8-1.2 mEq/L</strong></p>\n<p>For <strong>prophylaxis</strong> (to prevent relapse of bipolar disorder):&nbsp;<strong>0.5-0.8 mEq/L</strong></p>\n<p><strong>Toxic</strong> levels of lithium:&nbsp;<strong>&gt;/= 1.5 mEq/L</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Contraindications</strong>:</div>\n<div>\n<ul>\n<li>CKD</li>\n<li>Heart disease</li>\n<li>Hyponatremia or diuretic use</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Baseline studies:</strong></div>\n<div>\n<ul>\n<li>BUN (Blood Urea Nitrogen), Creatinine, Calcium, Urine analysis</li>\n<li>Thyroid function test</li>\n<li>ECG in patients with coronary risk factors</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Acute a</strong><strong>dverse effects</strong>:</div>\n<div>\n<ul>\n<li>Tremor, ataxia, weakness</li>\n<li>Polyuria, polydipsia</li>\n<li>Vomiting, diarrhea</li>\n<li>Cognitive impairment</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Chronic a</strong><strong>dverse effects</strong>:</div>\n<div>\n<ul>\n<li>Nephrogenic diabetes insipidus</li>\n<li>Thyroid dysfunction</li>\n<li>Hyperparathyroidism</li>\n</ul>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0611",
      "difficulty": "easy"
    },
    {
      "text": "A 28-year-old woman on lithium therapy now presents with a positive urine pregnancy test. Which of the following teratogenic effects can be expected in the fetus?",
      "choices": [
        {
          "id": 1,
          "text": "Cardiac defects"
        },
        {
          "id": 2,
          "text": "Facial defects"
        },
        {
          "id": 3,
          "text": "CNS defects"
        },
        {
          "id": 4,
          "text": "Urogenital defects"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Lithium</strong> use in pregnancy can lead to&nbsp;<strong>cardiac defects</strong>.&nbsp;</p>\n<p><strong>Ebstein's anomaly </strong>is the&nbsp;specific cardiac defect with lithium use in pregnancy.</p>\n<p>In Ebstein&rsquo;s anomaly, the&nbsp;radiological sign seen is a <strong>box-shaped heart</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4eda5b58e2f64337b1330f34da988cbax510x487.GIF\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Teratogenic drugs and the birth defects</h3><table>\n<tbody>\n<tr>\n<td><strong>Drugs</strong></td>\n<td><strong>Adverse effects</strong></td>\n</tr>\n<tr>\n<td>Penicillamine</td>\n<td>Cutis laxa syndrome</td>\n</tr>\n<tr>\n<td><strong>Lithium</strong></td>\n<td><strong>Ebstein anomaly</strong></td>\n</tr>\n<tr>\n<td>Isotretinoin</td>\n<td>Facial-ear anomalies, heart disease, CNS anomalies</td>\n</tr>\n<tr>\n<td>Progesterone</td>\n<td>Masculinization of the female fetus</td>\n</tr>\n<tr>\n<td>Quinine</td>\n<td>Abortion, thrombocytopenia, deafness</td>\n</tr>\n<tr>\n<td>Topiramate</td>\n<td>Cleft lip</td>\n</tr>\n<tr>\n<td><strong>Valproate</strong></td>\n<td>Spina bifida, limb defects, <strong>autism spectrum disorder</strong>, facial and cardiac anomalies, <strong>Coarctation of the aorta</strong>, Aortic stenosis, Pulmonary atresia, Ventricular Septal Defect. </td>\n</tr>\n<tr>\n<td><strong>Vitamin D</strong></td>\n<td><strong>Supravalvular aortic stenosis</strong></td>\n</tr>\n<tr>\n<td><strong>Warfarin</strong></td>\n<td>Fetal bleeding, <strong>hypoplastic nasal structures</strong></td>\n</tr>\n<tr>\n<td><strong>Statins</strong></td>\n<td>Vertebral, anal, cardiac, tracheoesophageal fistula, renal, arterial, limb (<strong>VACTERAL</strong>) defects</td>\n</tr>\n<tr>\n<td><strong>Phenytoin</strong></td>\n<td>Ventricular septal defect, Atrial Septal Defect, Coarctation of the aorta, Patent Ductus Arteriosus</td>\n</tr>\n<tr>\n<td>ACE inhibitors and ARBs</td>\n<td>\n<p>Hypoplasia of organs, anuria, irreversible renal failure</p>\n</td>\n</tr>\n<tr>\n<td>Carbimazole and Methimazole</td>\n<td> \n<p>Choanal atresia, aplasia cutis, tracheoesophageal fistula and fetal goiter</p>\n</td>\n</tr>\n<tr>\n<td>Alcohol</td>\n<td>Atrial Septal Defect, Ventricular Septal Defect</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1043",
      "difficulty": "easy"
    },
    {
      "text": "Which drug, when given to a mother in her third trimester of pregnancy, would result in the following finding in her newborn?",
      "choices": [
        {
          "id": 1,
          "text": "Venlafaxine"
        },
        {
          "id": 2,
          "text": "Diazepam"
        },
        {
          "id": 3,
          "text": "Promethazine"
        },
        {
          "id": 4,
          "text": "Clozapine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Benzodiazepines, when given during the third trimester of pregnancy can lead to <strong>floppy baby syndrome.</strong></p>\n<p>Benzodiazepines in pregnancy:</p>\n<ul>\n<li>First trimester - cleft palate, GI anomalies</li>\n<li>Third trimester - floppy baby syndrome with neonatal hypotonia, as a withdrawal effect.</li>\n</ul>\n<p>Note: Fetal lithium exposure is also associated with floppy baby syndrome.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a50a926d8c414f2680622a248acb29dax1280x2559.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/989df78e2cda415ebb5241aa72ffb54f.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5934",
      "difficulty": "hard"
    }
  ]
}